Yong Peng

This inventor holds 26 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 13 EPO patents. Top assignees: Centaurus Biopharma Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2015-2025.

USPTO Granted Patents = 26 (Patent Applications = 7)

% Patents Active = 73.1

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 61(Granted Patents)

Location History:

Beijing, CN (2016 - 2022)
Shenzhen, CN (2015 - 2023)

Company Filing History:

14 out of 33

Centaurus Biopharma Co., Ltd.

patents

12 out of 121

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

11 out of 26

Lianyungang Runzhong Pharmaceutical Co., Ltd.

patents

4. 4 out of 18,295

Boe Technology Group Co., Ltd.

patents

5. 3 out of 2,314

Beijing Boe Optoelectronics Technology Co., Ltd.

patents

6. 3 out of 27,557

Huawei Technologies Co., Limited

patents

7. 2 out of 5,337

Tencent Technology (Shenzhen) Company Limited

patents

8. 1 out of 5

Beijing Shenogen Pharma Group Ltd.

patents

9. 1 out of 1

Centaurus Biophrama Co., Ltd.

patent

10. 1 out of 17

Chongqing Boe Smart Electronics System Co., Ltd.

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12333263 - Content translation method and terminal (2025-06-17),

2. 12209074 - SHP2 phosphatase allosteric inhibitor (2025-01-28),

3. 11847314 - Machine translation method and electronic device (2023-12-19),

4. 11526476 - File system permission setting method and apparatus (2022-12-13),

5. 11380714 - Array substrate, display panel and display device (2022-07-05),

6. 11348544 - Electronic paper display apparatus and driving method thereof (2022-05-31),

7. 11203586 - Iridinesulfonamide compound and use method thereof (2021-12-21),

8. 11111240 - Sultam compound and application method thereof (2021-09-07),

9. 10923513 - Array substrate and method for manufacturing the same, display device (2021-02-16),

10. 10829492 - Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor (2020-11-10),

11. 10747349 - Display substrate, display panel, display apparatus and method for driving the same (2020-08-18),

12. 10745383 - 1,3,5-triazine derivative and method of using same (2020-08-18),

13. 10570141 - Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof (2020-02-25),

14. 10561657 - Pyrrolopyrimidine compound (2020-02-18),

15. 10329277 - N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity (2019-06-25),

Title: Inventor Yong Peng - Revolutionizing Technology in Beijing

Introduction: Yong Peng is a visionary inventor based in Beijing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yong Peng holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his commitment to pushing the boundaries of what is possible in the tech industry.

Career Highlights: With a career spanning over two decades, Yong Peng has worked with leading tech companies in Beijing, spearheading research and development projects that have led to significant advancements in various technological domains.

Collaborations: Throughout his career, Yong Peng has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge sharing in the tech community.

Conclusion: Yong Peng's relentless pursuit of innovation and his passion for creating technology that makes a difference have solidified his reputation as a pioneering inventor in Beijing and beyond.